Orthofix International N.V. (NASDAQ:OFIX) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share guidance of $1.54-1.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.53. The company issued revenue guidance of $422-425 million, compared to the consensus revenue estimate of $414.14 million.

Orthofix International N.V. (NASDAQ OFIX) opened at 48.33 on Wednesday. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $49.60. The company’s market cap is $872.07 million. The company’s 50-day moving average price is $45.44 and its 200-day moving average price is $40.49.

Orthofix International N.V. (NASDAQ:OFIX) last posted its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The company had revenue of $108.90 million during the quarter, compared to analyst estimates of $102.94 million. Orthofix International N.V. had a return on equity of 10.04% and a net margin of 1.88%. Orthofix International N.V.’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.41 earnings per share. Equities research analysts expect that Orthofix International N.V. will post $1.55 EPS for the current fiscal year.

A number of analysts have weighed in on the company. BidaskClub lowered Orthofix International N.V. from a buy rating to a hold rating in a report on Tuesday, August 1st. Zacks Investment Research upgraded Orthofix International N.V. from a sell rating to a hold rating in a report on Thursday, July 6th. BTIG Research assumed coverage on Orthofix International N.V. in a report on Wednesday, June 21st. They set a buy rating and a $52.00 target price for the company. Langenberg & Company restated a buy rating and set a $53.25 target price on shares of Orthofix International N.V. in a report on Wednesday, June 14th. Finally, Ladenburg Thalmann Financial Services assumed coverage on Orthofix International N.V. in a report on Wednesday, June 14th. They set a buy rating and a $53.25 target price for the company. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Orthofix International N.V. currently has an average rating of Buy and an average price target of $51.88.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/09/orthofix-international-n-v-ofix-updates-fy17-earnings-guidance.html.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.